Literature DB >> 19365738

Intensive chemotherapy failure in Burkitt's lymphoma with cavernous sinus involvement.

Zhi-Yu Chen1, Bin Wu, Ji-Liang Yin.   

Abstract

Burkitt's lymphoma is an aggressive B-cell lymphoma with rapid proliferative index, which makes it disseminate easily to distal sites, especially to bone marrow and the central nerve system. We report here a 22-year-old woman with Burkitt's lymphoma involving multiple organs, including kidneys, breasts, left ovary, and bone marrow at the time of diagnosis. The patient responded well to intensive chemotherapy before the onset of retro-orbital pain, vomiting, and photophobia. The contrast-enhanced T1-weighted image in a second magnetic resonance image (MRI) showed a 2 x 1.9 cm mass in her left cavernous sinus that was not found in her initial MRI. Central nervous system (CNS)-directed high-dose chemotherapy and whole-brain radiation could not change the final failed treatment outcome caused by the cavernous sinus involvement disseminating to her entire CNS. Further study should provide well-designed therapeutic strategies to Burkitt's patients with cavernous sinus involvement.

Entities:  

Mesh:

Year:  2009        PMID: 19365738     DOI: 10.1007/s12032-009-9213-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  18 in total

1.  Burkitt lymphoma presenting with gingival pain and a cavernous sinus syndrome in an adult.

Authors:  Michael S Vaphiades; Andrew G Lee
Journal:  J Neuroophthalmol       Date:  2005-09       Impact factor: 3.042

Review 2.  Cavernous sinus involvement by extramedullary plasmacytoma of the sphenoid sinus. An argument for the use of adjuvant chemotherapy.

Authors:  Federico L Ampil; T Greg Borski; Cherie Ann O Nathan; Gregory Mulcahy; Michael Walker; Hong W Chin; Fred J Stucker
Journal:  Leuk Lymphoma       Date:  2002-10

3.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Authors:  T A Lister; D Crowther; S B Sutcliffe; E Glatstein; G P Canellos; R C Young; S A Rosenberg; C A Coltman; M Tubiana
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

4.  Extramedullary plasmacytoma of the cavernous sinus.

Authors:  I Vande Broek; T Stadnik; A Meurs; J Maes; B Van Camp; R Schots
Journal:  Leuk Lymphoma       Date:  2002-08

5.  Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

Authors:  L D Kaplan; D J Straus; M A Testa; J Von Roenn; B J Dezube; T P Cooley; B Herndier; D W Northfelt; J Huang; A Tulpule; A M Levine
Journal:  N Engl J Med       Date:  1997-06-05       Impact factor: 91.245

6.  Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.

Authors:  D A Thomas; J Cortes; S O'Brien; S Pierce; S Faderl; M Albitar; F B Hagemeister; F F Cabanillas; S Murphy; M J Keating; H Kantarjian
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

7.  Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.

Authors:  Eunice S Wang; David J Straus; Julie Teruya-Feldstein; Jing Qin; Carol Portlock; Craig Moskowitz; Andre Goy; Eric Hedrick; Andrew D Zelenetz; Ariela Noy
Journal:  Cancer       Date:  2003-09-15       Impact factor: 6.860

8.  Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.

Authors:  I Magrath; M Adde; A Shad; D Venzon; N Seibel; J Gootenberg; J Neely; C Arndt; M Nieder; E Jaffe; R A Wittes; I D Horak
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

Review 9.  Adult Burkitt leukemia and lymphoma.

Authors:  Kristie A Blum; Gerard Lozanski; John C Byrd
Journal:  Blood       Date:  2004-07-20       Impact factor: 22.113

10.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

View more
  1 in total

1.  Isolated third nerve palsy: a rare neurological presentation of Burkitt's lymphoma.

Authors:  Siddhesh Arun Kalantri; Akshatha Nayak; Saikat Datta; Maitreyee Bhattacharyya
Journal:  BMJ Case Rep       Date:  2017-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.